Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood

International Journal of Antimicrobial Agents

Volumn 37, Issue 5, 2011, Pages 472-475

  Esposito, Susanna ^a   Tagliabue, Claudia ^a   Bosis, Samantha ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Children; Fluoroquinolones; Levofloxacin; Macrolides; Meningoencephalitis; Mycoplasma pneumoniae

Indexed keywords

ACICLOVIR; BACTERIAL DNA; C REACTIVE PROTEIN; CEFTRIAXONE; CLONAZEPAM; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEVOFLOXACIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; MALE; MENINGISM; MENINGOENCEPHALITIS; MYCOPLASMA PNEUMONIAE; NEUROLOGIC DISEASE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEIZURE; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MENINGOENCEPHALITIS; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE; OFLOXACIN;

EID: 79953880756     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.01.008     Document Type: Article

References (15)

1. Christie LJ, Honarmand S, Talkington DF, Gavali SS, Preas C, Pan CY, et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 2007;120:305-13.
2. Tsiodras S, Kelesidis I, Kelesidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect 2005;51:343-54. (Pubitemid 43008958)
3. Bitnum A, Ford-Jones EL, Petric M, MacGregor D, Heurter H, Nelson S, et al. Acute childhood encephalitis and Mycoplasma pneumonia. Clin Infect Dis 2001;32:1674-84. (Pubitemid 32536804)
4. Bitnum A, Ford-Jones E, Blaser S, Richardson S. Mycoplasma pneumoniae encephalitis. Semin Pediatr Infect Dis 2003;14:96-107. (Pubitemid 36859263)
5. Kusunoki S, Shiina M, Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to Mycoplasma infection: evidence of molecular mimicry. Neurology 2001;57:736-8. (Pubitemid 32783015)
6. Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A 2006;103:6724-9.
7. Waites KB, Talkington DF. Mycoplasma pneumonia and its role as a human pathogen. Clin Microbiol Rev 2004;17:697-728. (Pubitemid 39372513)
8. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections. Lancet Infect Dis 2001;1:334-44. (Pubitemid 33586614)
9. Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 2009;64:52-8.
10. Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J 2009;28:693-6.
11. Nau R, Sörgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010;23:858-83.
12. Schaad UB. Will fluoroquinolones ever be recommended for common infections in children? Pediatr Infect Dis J 2007;26:865-7.
13. Esposito S, Bosis S, Begliatti E, Droghetti R, Tremolati E, Tagliabue C, et al. Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. Clin Infect Dis 2006;43:206-9.
14. Duffy LB, Crabb DM, Bing X, Waites KB. Bactericidal activity of levofloxacin against Mycoplasma pneumonia. J Antimicrob Chemother 2003;52:527-8. (Pubitemid 37120745)
15. Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, Phuenpathom N, Tussanasunthornwong S. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother 1996;40:825-6. (Pubitemid 26071561)